H-ciPTECs increased collagen IV deposition when co-treated with TGF-β, while this was not observed in the sham, vehicle and ischemic groups, confirming the efficacy of our model to mimic the progression to chronic kidney disease observed after AKI (Additional file 1: Fig. S1). Here, TGFB1 is linked to acute kidney injury.